Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 234-465-8 | CAS number: 12005-21-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Description of key information
The variations L181 and L175G25C4G were tested for acute oral toxicity.
The variation L175G25C4G was tested for acute toxicity via the inhalation route.
The variation L181 was tested for acute dermal toxicity.
None of the variations showed any acute toxicity or other treatment-related adverse effects in any of the 3 routes.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- The actual LD50 is > 2000 mg/kg, but IUCLID does not allow to enter this value.
The quality of the entire database is K1.
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2010-11-02 to 2011-05-17
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan, Indianapolis, Indiana, USA
- Age at study initiation: 8 - 9 weeks
- Weight at study initiation: males 224 - 238 g, females 177 - 190 g
- Housing: Singly housed in suspended stainless steel cages with mesh floors. Litter paper was placed beneath the cage and was changed at least 3 times per week.
- Diet (e.g. ad libitum): ad libitum except during exposure
- Water (e.g. ad libitum): ad libitum except during exposure
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 - 23 °C
- Humidity (%): 42 - 66 %
- Air changes (per hr): 12
- Photoperiod (hrs dark / hrs light): 12 / 12
IN-LIFE DATES: From: 2011-04-26 To: 2011-05-17 - Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- nose only
- Vehicle:
- clean air
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: Nose Only Inhalation chamber, ADG Developments Ltd.
- Exposure chamber volume: 28 L
- Method of holding animals in test chamber: Animals were individually housed in polycarbonate holding tubes which seal to the chamber with an "O" ring during exposure.
- Source and rate of air: 40 L/min of filtered air by an air compressor (Airgas) to the dust generator. 65 L/min of compressed mixing air, supplied using air from a compressed air tank (Airgas) ---> total of 105 L/min.
- Method of conditioning air: Compressed mixing air was introduced into the chamber to help uniformly distribute the test atmosphere by creating a vortex at the chamber inlet.
- System of generating particulates/aerosols: The ungrounded substance was aerosolised using a Dust generator (fluid Energy jet-Mill, Serial # J296L with an Accurate series 100 Dry Material Feeder apparatus.
- Method of particle size determination: An eight stage ACFM Andersen ambient Particle Sizing Sampler was used to assess the particle size distribution of the test atmosphere. Samples were withdrawn from the breathing zone of the animals in 2 intervals. The filtre paper collection stages were weighed before and after sampling to determine the mass collected upon each stage. the aerodynamic mass median diameter and geometric standard deviation were determined graphically using tow-cycle logarithmic probit axis.
- Treatment of exhaust air: no data
- Temperature, humidity, pressure in air chamber: Exposure tube: 20 - 22 °C, 59 - 67 %. Room temperature 20 - 22 °C, 53 - 60 %.
TEST ATMOSPHERE
- Brief description of analytical method used: see particle size determination
- Samples taken from breathing zone: yes
VEHICLE
- Composition of vehicle (if applicable): air
- Concentration of test material in vehicle (if applicable): 5.14 mg/l
TEST ATMOSPHERE (if not tabulated)
- Particle size distribution: see table in "divers1.doc", attached documents
- MMAD (Mass median aerodynamic diameter) / GSD (Geometric st. dev.): see table in "divers1.doc", attached documents
CLASS METHOD (if applicable)
- Rationale for the selection of the starting concentration: Desired chamber concentration was 5.0 mg/L. 12 pre-test trials were conducted to establish generation procedures to achieve, to the extent possible, the desired chamber concentration. The procedures and aerosolisation equipment finally chosen for the full test provided a chamber concentration of 5.14 mg/L. - Analytical verification of test atmosphere concentrations:
- yes
- Remarks:
- Chamber concentration and particle size distribution were determined periodically during the exposure period
- Duration of exposure:
- ca. 241 min
- Remarks on duration:
- Animals exposed to the test atmosphere for 241 min. Exposure period extended beyond 4 h to allow the chamber to reach equilibrium (T99). 99% equlibration was reached after 1 min.
- Concentrations:
- 5.14 mg/L
- No. of animals per sex per dose:
- 5 males, 5 females
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Weighing prior to test substance exposure Initial) and on days 1, 3, 7 and 14. Observation for mortality during exposure period. Examinations for gross toxicity and behavioral changes upon removal from the exposure tube and at least once daily thereafter for 14 days.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, organ weights, histopathology, other: body weight - Statistics:
- As for particle size distribution see "GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION"
- Preliminary study:
- The desired chamber concentration was 5.0 mg/L and the desired chamber particle size distribution (mass median aerodynamic diameter) was 1 and 4 µm. 12 pre-test trials were conducted to establish generation procedures to achieve, to the extent possible, the desired chamber concentration and particle size distribution. in these trials the following adjustemnts were made in an attempt to achieve these objectives:
- generation system
- test substance concentration
- compressed mixing air
- total airflow
- test substance delivery method
- chamber size
- pump setting / motor setting - Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 5.14 mg/L air
- Based on:
- test mat.
- Exp. duration:
- 241 min
- Mortality:
- No mortality observed
- Clinical signs:
- other: Following exposure of the test atmosphere, 1 male and 2 females exhibited irregular respiration, but recovered by day 2 and along with the other animals appeared active and healthy for the remainder of the study. Although mist animals lost weight by day 1
- Body weight:
- Body weights [g]
Animal No. Sex initial day 1 day 3 day 7 day 14
3301 M 227 228 242 269 304
3302 M 235 240 244 272 292
3303 M 224 221 231 257 283
3304 M 238 239 251 283 313
3305 M 235 231 245 270 299
3306 F 177 173 177 189 200
3307 F 190 187 197 200 218
3308 F 185 186 189 207 210
3309 F 188 183 194 204 219
3310 F 189 187 193 205 214 - Gross pathology:
- No gross abnormalities were noted.
- Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Under the conditions of this study, the single exposure acute inhalation LC50 of L175G25C4G is > 5.14 mg/L in male and female rats. Based on the results of this study L175G25C4G does not require C&L as to the CLP-Regulation 1272/2008.
- Executive summary:
An acute inhalation toxicity test was conducted with rats to determine the potential for L175G25C4G to produce toxicity from a 4 -hour exposure via the inhalation route.
After establishing the desired generation procedures during pre-test trials, 5 healthy female and male rats were exposed to the test atmosphere for 4 hours. Chamber concentration and particle size distribution were determined periodically during the exposure period. The animals were observed for mortality, signs of gross toxicity, and behavioral changes at least once daily for 14 days following exposure. Body weights were recorded prior to exposure and again on days 1,3, 7 and 14. Necropsies were performed on all animals at terminal sacrifice. No gross abnormalities were noted.
Under the conditions of this study, the single exposure acute inhalation LC50 of L175G25C4G is > 5.14 mg/L in male and female rats. Based on the results of this study L175G25C4G does not require C&L as to the CLP-Regulation 1272/2008.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating conc.
- Value:
- 5 140 mg/m³
- Quality of whole database:
- The actual LC50 is > 51240 mg/kg, but IUCLID does not allow to enter this value.
The quality of the entire database is K1.
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2010-12-09 to 2010-12-29
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
- Reason / purpose for cross-reference:
- reference to other study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River, 97633 Sulzfeld, Germany
- Age at study initiation: males 8 - 9 weeks, females 14 weeks
- Weight at study initiation (administration): males 248 - 252 g, females 208-230 g
- Housing: full barrier in an air-conditioned room
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 6 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 3 °C
- Humidity (%): 55 +/- 10 %
- Air changes (per hr): 10 12 / 12
- Photoperiod (hrs dark / hrs light):
IN-LIFE DATES: From: 2010-012-09 To: 2012-12-29 - Type of coverage:
- occlusive
- Vehicle:
- water
- Remarks:
- Aqua ad injectionem (Berlin Chemie, lot no. 01954, expiry date 04/2013)
- Details on dermal exposure:
- TEST SITE
- % coverage: ca. 10
- Type of wrap if used: additional dressing
REMOVAL OF TEST SUBSTANCE
- Washing (if done): yes; aqua ad injecionem
- Time after start of exposure: 24 h
TEST MATERIAL
- Constant volume or concentration used: yes
- For solids, paste formed: moisted with water
VEHICLE
- Lot/batch no. (if required): Berlin Chemie, lot no. 01954, expiry date 04/2013 - Duration of exposure:
- 24 h
- Doses:
- 2000 mg/kg body weight
- No. of animals per sex per dose:
- 5 each
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Weighing in day 1 (prior to application), day 8, day 15. A careful clinical observation was made several times on the day of dosing (at least during the first 30 minutes and with special attention given during the first 4 hours post dose). thereafter, the animals were observed for clinical signs once daily until the end of the observation period.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, organ weights, histopathology, other: body weight - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality observed.
- Clinical signs:
- Nasal discharge 1h, 2 h, 3 h and 4 h post dose which is not considered to be test-item related.
- Body weight:
- body weight [g] and body weight gain [%]
Animal No. / Sex day 1 day 8 day 15 % day 1 -15
21 / M 252 268 300 19
22 / M 252 279 314 25
23 / M 251 270 305 22
24 / M 248 272 300 21
25 / M 250 274 308 23
11 / F 227 223 228 0.4
12 / F 220 217 230 4.5
13 / F 208 206 210 1
14 / F 230 240 249 8
15 / F 220 217 229 4 - Gross pathology:
- With the exception of acute injection of blood vessels in the abdominal region, which is due to the euthanasia injection, no specific gross pathological changes were recorded for any animal.
- Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- After an application period of 24 hours followed by an observation period of 14 days, no mortality and other adverse effects were observed. L181is non-toxic via the dermal route according to CLP
- Executive summary:
The acute dermal toxicity of L181 was assessed in a GLP limit test according to OECD 402. 2000 mg/kg body weight of the test item were applied on the skin of Wistar rats (5 males, 5 females). The exposure period was 24 hours followed by an observation period of 14 days.
Erythema grade1 were observed in 2 of 5 female animals. Desquamination was observed in 1 of 5 female animals. Eschar was observed in 3 of 5 female animals. Scratches were observed in 3 of 5 female and 2 of 5 male animals. All sings of irritation were reversible within the observation period.
No mortalities and no treatment-related other adverse effects were observed.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- The actual LD50 is > 2000 mg/kg, but IUCLID does not allow to enter this value.
The quality of the entire database is K1.
Additional information
The variations L181 and L175G25C4G were tested for acute oral toxicity in a GLP guideline studies according to OECD 423.
The variation L175G225C4G was tested for acute toxicity via the inhalation route in a GLP guideline study according to OECD 403.
The variation L181 was tested for acute dermal toxicity in a GLP guideline study according to OECD 402.
Both variations did not exhibit any acute toxicity via any route of exposure.
The studies for the inhalation route and the dermal route are not required under REACH for the tonnage band 1 - 10 t/a. The results of the 4 studies on acute toxicity reveal the same toxicological profile for both variations. The same toxicological profile is expected for other variations of the substance pentaaluminium triyttrium dodecaoxide.
Justification for selection of acute toxicity – oral endpoint
Both studies were selected.
Justification for selection of acute toxicity – inhalation endpoint
Study available
Justification for selection of acute toxicity – dermal endpoint
Study available
Justification for classification or non-classification
Pentaaluminium triyttrium dodecaoxide did not show any acute toxicity via the oral or dermal or the inhalation route. C&L is not required.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)